OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
Emily A. Dickie, Federica Giordani, Matthew K. Gould, et al.
Tropical Medicine and Infectious Disease (2020) Vol. 5, Iss. 1, pp. 29-29
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020
José R. Franco, Giuliano Cecchi, Massimo Paone, et al.
PLoS neglected tropical diseases (2022) Vol. 16, Iss. 1, pp. e0010047-e0010047
Open Access | Times Cited: 130

Anti-trypanosomatid drug discovery: progress and challenges
Manu De Rycker, Susan Wyllie, David Horn, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 35-50
Open Access | Times Cited: 126

Current Treatments to Control African Trypanosomiasis and One Health Perspective
Alberto Venturelli, Lorenzo Tagliazucchi, Clara Lima, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1298-1298
Open Access | Times Cited: 48

Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections
Srinivasa P. S. Rao, Matthew K. Gould, Jonas Noeske, et al.
Science (2023) Vol. 380, Iss. 6652, pp. 1349-1356
Open Access | Times Cited: 24

Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies
Marzuq A. Ungogo, Harry P. de Koning
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 25, pp. 100533-100533
Open Access | Times Cited: 13

Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
Manuel Saldivia, Eric Fang, Xiaolei Ma, et al.
Nature Microbiology (2020) Vol. 5, Iss. 10, pp. 1207-1216
Open Access | Times Cited: 61

Recent progress in diagnosis and treatment of Human African Trypanosomiasis has made the elimination of this disease a realistic target by 2030
Andrés Álvarez-Rodríguez, Bo-kyung Jin, Magdalena Radwanska, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 34

Catalyst-Free C(sp2)-H Borylation through Aryl Radical Generation from Thiophenium Salts via Electron Donor–Acceptor Complex Formation
Bo Li, Ke Wang, Huifeng Yue, et al.
Organic Letters (2022) Vol. 24, Iss. 40, pp. 7434-7439
Closed Access | Times Cited: 31

New drug approvals for 2021: Synthesis and clinical applications
Shuo Yuan, Dan-Shu Wang, Hui Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114898-114898
Closed Access | Times Cited: 31

Impact of pulmonary African trypanosomes on the immunology and function of the lung
Dorien Mabille, Laura Dirkx, Sofie Thys, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 128-128
Open Access | Times Cited: 29

The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration
Kenneth Pfarr, Anna K. Krome, Issraa Al-Obaidi, et al.
Parasites & Vectors (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 19

Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
Miebaka Jamabo, Maduma Ernst Mahlalela, Adrienne L. Edkins, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12529-12529
Open Access | Times Cited: 17

Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds
Gonzalo Scalese, María Florencia Mosquillo, Leticia Pérez‐Díaz, et al.
Coordination Chemistry Reviews (2024) Vol. 503, pp. 215608-215608
Closed Access | Times Cited: 8

Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
Marie-José Bijlmakers
Frontiers in Chemistry (2021) Vol. 8
Open Access | Times Cited: 35

Synthetic Approaches to the New Drugs Approved During 2021
Emma L. McInturff, Scott P. France, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10150-10201
Closed Access | Times Cited: 15

Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei
Karol R. Francisco, Ludovica Monti, Wenqian Yang, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 81, pp. 129123-129123
Open Access | Times Cited: 11

Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?
Maura Rojas-Pirela, Ulrike Kemmerling, Wilfredo Quiñones, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 599-599
Open Access | Times Cited: 11

Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates
Carlos García‐Estrada, Yolanda Pérez‐Pertejo, Bárbara Domínguez-Asenjo, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 637-637
Open Access | Times Cited: 11

Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases
Igor José dos Santos Nascimento, Misael de Azevedo Teotônio Cavalcanti, Ricardo Olímpio de Moura
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115550-115550
Closed Access | Times Cited: 11

Metal complexes as potential anti-Trypanosoma agents: a bibliographic review
Silvania Siqueira Nogueira, Paulo Sérgio de Araújo Sousa, M Fochesato, et al.
Caderno Pedagógico (2025) Vol. 22, Iss. 4, pp. e14464-e14464
Closed Access

Cytological profiling of trypanocidal principles from Aloe barbadensis and Taraxacum officinale
Pearl Ihuoma Akazue, Neils B. Quashie, Dorcas Osei‐Safo, et al.
Phytomedicine Plus (2025), pp. 100793-100793
Open Access

Total synthesis of (+)-spiroindimicin A and congeners unveils their antiparasitic activity
Zhen Zhang, S. Ray, Leah S. Imlay, et al.
Chemical Science (2021) Vol. 12, Iss. 30, pp. 10388-10394
Open Access | Times Cited: 26

Page 1 - Next Page

Scroll to top